Betaxolol recalls

The FDA has published 3 recalls involving Betaxolol since 2021. The latest was reported on 25 Oct 2023. Most were for sterility. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2021
Last 12 months0reported
Class I133% of total
Ongoing1latest 25 Oct 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 33%Class II 2 67%Class III 0 0%

Why betaxolol is recalled

Companies

By year

Ongoing betaxolol recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIBetaxolol Ophthalmic Solution recalled by AkornAkornManufacturing (CGMP) DeviationsNationwide

All betaxolol recalls, newest first

3 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IBetaxolol Tablets, USP 10 mg recalled by KVK-TechBetaxolol HydrochlorideKvk-TechOtherNationwide
DrugCLASS IIBetaxolol Ophthalmic Solution recalled by AkornAkornManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIBetaxolol Ophthalmic Solution recalled by AkornAkornSterilityNationwide

Should you stop taking Betaxolol?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.